Evidence map›Paper›PMID 42851829›Full record

ArticleACS omega2026

Diversity of Approaches to the Synthesis of Phosphoryl Guanidine Oligonucleotides.

Sergey A Zhukov, Maxim S Kupryushkin

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sergey A ZhukovKnorre Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of RAS, Lavrentiev Ave. 8, 630090 Novosibirsk, Russia.
Maxim S KupryushkinKnorre Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of RAS, Lavrentiev Ave. 8, 630090 Novosibirsk, Russia.ORCID https://orcid.org/0000-0002-2300-7809

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphoryl guanidines represent a class of internucleotide phosphate modifications introduced at the oxidation step of automated solid-phase oligonucleotide synthesis. The procedures for obtaining these modifications are fully compatible with the standard reagent set and the protocols. Phosphoryl guanidine modifications enable not only altering the nature of the backbone but also introducing various substituents into the oligonucleotide structure. This study investigates the applicability of various alternative oxidation methods for the preparation of diverse representatives of phosphoryl guanidines bearing various substituents and explores the feasibility of implementing various synthetic schemes within these methods. In this work, the scope of the oxidative amination of phosphite triesters was expanded. Diverse representatives of the class were obtained both by introducing different guanidine residues and by using O-methyl isourea as a common precursor for the synthesis of various phosphoryl guanidines. The feasibility of using the oxidative amination of H-phosphonates via the Atherton-Todd reaction to obtain phosphoryl guanidine derivatives was demonstrated here. To obtain phosphoryl guanidine derivatives by oxidation of phosphite triesters with electron-deficient azides via the Staudinger reaction, new synthetic schemes for diaminocarbenium azides were implemented, enabling the preparation of asymmetric tetrasubstituted azides and unsubstituted guanyl azide. Using these azides, the corresponding phosphoryl guanidine derivatives were successfully obtained. The possibility of obtaining multiply modified oligonucleotides with various substituents on the guanidine group has been demonstrated. The proposed methods enabled a significant expansion of the structural diversity of phosphoryl guanidine oligonucleotide derivatives.

Identifiers

PMID42851829
PMCPMC13647350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.